TZDs, GLP-1 agonist may worsen diabetic retinal disease

Two classes of drugs commonly used to treat type 2 diabetes and theoretically prevent its complications may instead be associated with progression of diabetic retinal disease, said investigators in two studies presented here.

Related Videos

Related Content

Advertisement

January 15th 2025

FDA proposes mandatory front-of-package nutrition label; residents of unburned homes report health symptoms months following wildfires; opioid pain medications rarely prescribed to NFL players – Morning Medical Update

January 13th 2025

Ep. 47: Weight loss drugs with Robert Kushner, MD

January 14th 2025

USPSTF recommends osteoporosis screening for women aged 65 and older

January 6th 2025

Ep. 46: Social media health information with Richard Miller, MD

January 14th 2025

Are Medicare Advantage plans really providing supplemental benefits as advertised?

January 14th 2025

The first line of defense: How primary care doctors can guide patients through a cancer diagnosis

Related Content

Advertisement

January 15th 2025

FDA proposes mandatory front-of-package nutrition label; residents of unburned homes report health symptoms months following wildfires; opioid pain medications rarely prescribed to NFL players – Morning Medical Update

January 13th 2025

Ep. 47: Weight loss drugs with Robert Kushner, MD

January 14th 2025

USPSTF recommends osteoporosis screening for women aged 65 and older

January 6th 2025

Ep. 46: Social media health information with Richard Miller, MD

January 14th 2025

Are Medicare Advantage plans really providing supplemental benefits as advertised?

January 14th 2025

The first line of defense: How primary care doctors can guide patients through a cancer diagnosis